Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$26,891,222
+$6,519,237 QoQ
Shares Held
22,420
+1.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#760
of 4,604 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Dec 31, 2021CallValue
$276,220
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RITHOLTZ WEALTH MANAGEMENT holds $147,518,356 across 14 Drug Manufacturers - General names. LLY ranks #1 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
22,420 | $26,891,222 | |
| 2 | JNJ |
Johnson & Johnson
|
101,232 | $25,709,891 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
135,292 | $17,092,791 | |
| 4 | NVS |
Novartis AG
|
105,819 | $16,583,953 | |
| 5 | ABBV |
AbbVie Inc.
|
49,487 | $12,452,908 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
169,475 | $9,765,149 | |
| 7 | BIIB |
Biogen Inc.
|
34,283 | $7,407,184 | |
| 8 | AZN |
Astrazeneca PLC
|
34,429 | $6,528,426 |
All Filings in LLY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,891,222 | 22,420 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $20,371,985 | 22,149 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $23,839,628 | 22,183 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $17,561,208 | 23,016 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $17,258,014 | 22,139 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $17,405,227 | 21,074 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $16,364,856 | 21,198 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $18,787,243 | 21,206 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $20,889,832 | 23,073 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $18,114,020 | 23,284 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $13,454,959 | 23,082 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $13,238,105 | 24,646 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $11,414,973 | 24,340 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $8,131,842 | 23,679 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $9,111,976 | 24,907 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $8,630,211 | 26,690 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $3,121,037 | 9,626 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $2,223,949 | 7,766 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $276,220 | 1,000 | Call | Sole | 2022-01-18 | |
| 2021-12-31 | $1,399,882 | 5,068 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $937,831 | 4,059 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $866,438 | 3,775 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $560,273 | 2,999 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $594,147 | 3,519 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $507,116 | 3,426 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $577,913 | 3,520 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $307,819 | 2,219 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||